Author

J. W. Choi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:imaging· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

B. K. Jang· 1 shared B. Kim· 1 shared C. J. Lee· 1 shared D.-W. Cho· 1 shared H. H. Yoon· 1 shared H. J. Song· 1 shared I. Y. Kim· 1 shared J. Y. Heo· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

B. K. Jang

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Testing in vitro toxicity of nanoparticles in 3D cell culture with various extracellular matrix scaffold

J. W. Choi, S.-H. Bae, I. Y. Kim, M. Kwak, T. G. Lee, M. B. Heo

This study compares the toxicity of 20 nm SiO2 nanoparticles in 2D and 3D cell cultures using different scaffolds, finding reduced toxicity in 3D cultures and scaffold-dependent effects in serum-free conditions.

bioRxiv · Mar 18, 2021 · PreprintPharmacology & Toxicology

Third-generation dual-source computed tomography of the abdomen: comparison of radiation dose and image quality of 80kVp and 80/150kVp with tin filter

S. J. Choi, S. H. Park, S. J. Ahn, S. H. Park, J. W. Choi, S. Y. Pak, Y. S. Shim, Y. M. Jeong, B. Kim

This study compares 80 kVp and 80/Sn150 kVp CT in oncology patients, finding 80 kVp provides better image quality and lower radiation dose.

PLOS ONE · Sep 3, 2020Peer-reviewedCancer Biology

KDS2010, a newly developed reversible MAO-B inhibitor, as an effective therapeutic candidate for Parkinson's disease

M.-H. Nam, J.-H. Park, H. J. Song, J. W. Choi, S. Kim, B. K. Jang, H. H. Yoon, J. Y. Heo, D.-W. Cho, Y.-S. Yang, S.-C. Han, S. Kim, S.-J. Oh, S. R. Jeon, K. D. Park, C. J. Lee

This paper tests KDS2010, a reversible MAO-B inhibitor, in PD animal models and finds it effective with low toxicity and superior neuroprotection compared to selegiline.

bioRxiv · Jul 6, 2020Pharmacology & Toxicology